Impact Sector
Human Health
- In vitro reactivity of fine and ultrafine particlesPrincipal Investigator: Jean-Jacques SauvainCountry: SwitzerlandFunding Source: French AFSSET and Institut universitaire romand de Santé au Travail
- In vivo imaging of diabetogenic cytotoxic T-lymphocytesPrincipal Investigator: Anna MooreCountry: USAFunding Source: NIH
- INFLAMMATORY AND GENOTOXIC EFFECTS OF ENGINEERED NANOMATERIALSPrincipal Investigator: Kai SavolainenCountry: EUFunding Source: DG Research
- Inflammatory and genotoxic effects of engineered nanoparticlesPrincipal Investigator: Kai SavolainenCountry: FinlandFunding Source: Finnish Work Environment Fund, Finnish Institute of Occupational Health
- Integrated Nanosystems for Diagnosis and TherapyPrincipal Investigator: Karen L WooleyCountry: USAFunding Source: NIH
- Interaction of ultrafine particles with the internal surface of the lungPrincipal Investigator: P. GehrCountry: SwitzerlandFunding Source: Bangerter-Stiftung
- Interactions Between Nanoscale Materials and Blood Principal Investigator: Jillian BuriakCountry: CanadaFunding Source: NSERC
- Interactions between semiconductor nanoparticles and biomembranes and DNA Principal Investigator: Jay NadeauCountry: CanadaFunding Source: NSERC
- Internalization and Fate of Individual Manufactured Nanomaterial within Living Cells Principal Investigator: Galya OrrCountry: USAFunding Source: EPA
- Interplay of lung cells and their cellular responses upon exposure to combustion-generated ultrafine particles and manufactured nanoparticlesPrincipal Investigator: Barbara Rothen-RutishauserCountry: SwitzerlandFunding Source: Swiss National Science Foundation
